Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Asset Utilization Ratio (2016 - 2025)

Medifast's Asset Utilization Ratio history spans 15 years, with the latest figure at 1.49 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 28.61% year-over-year to 1.49; the TTM value through Dec 2025 reached 1.49, down 28.61%, while the annual FY2025 figure was 1.45, 28.51% down from the prior year.
  • Asset Utilization Ratio reached 1.49 in Q4 2025 per MED's latest filing, down from 1.6 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 4.98 in Q4 2022 to a low of 1.49 in Q4 2025.
  • Average Asset Utilization Ratio over 5 years is 3.31, with a median of 3.66 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: grew 27.94% in 2022, then tumbled 39.75% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 3.97 in 2021, then grew by 25.47% to 4.98 in 2022, then tumbled by 31.59% to 3.4 in 2023, then plummeted by 38.48% to 2.09 in 2024, then dropped by 28.61% to 1.49 in 2025.
  • Per Business Quant, the three most recent readings for MED's Asset Utilization Ratio are 1.49 (Q4 2025), 1.6 (Q3 2025), and 1.75 (Q2 2025).